Diagnostic criteria for polycystic ovary syndrome (PCOS) have not been standardized until the recently postulated recommendations, while the classical European and American criteria are different. The controversies seem to have been resolved by the Rotterdam Consensus Conference held in 2003 where the gap between the European and American criteria was surmounted and standardized diagnostic recommendations were presented. Based on the new criteria the diagnosis of PCOS could be set if two of the three diagnostic criteria are fulfilled (oligo- or anovulation, clinical and/or biochemical signs of hyperandrogenism, polycystic ovaries) and furthermore, other diseases like 21 hydroxylase deficiency can be ruled out. Concerning the management of PCOS the recommendations are less evident, which may be attributable to the aetiological uncertainty. Treatment depends on the demands of the patient (infertility, hyperandrogenism), however the long-term metabolic risk (diabetes, metabolic syndrome) and the oncological risk (endometrial cancer) should also be considered. The use of insulin sensitizing agents has gained increasing significance for all the indications, as these may represent causal treatment, however their exact indications and the length of the treatment have not been clarified as yet.
|Number of pages||10|
|Journal||Magyar Noorvosok Lapja|
|Publication status||Published - Jul 28 2005|
ASJC Scopus subject areas
- Reproductive Medicine
- Obstetrics and Gynaecology